Stocks · News reference
Microbot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 3:17 PM
- Checked
- Aug 11, 2026, 3:17 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Microbot Medical shares are trading lower after B. Riley Securities lowered its price target on the stock from $5 to $4.
Read original at benzingaB. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4
B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.
Read original at benzinga